BioCentury
ARTICLE | Company News

GlaxoSmithKline, University of Dundee deal

June 13, 2011 7:00 AM UTC

GlaxoSmithKline partnered with the university to develop therapeutics to treat recessive dystrophic epidermolysis bullosa (RDEB), a condition where the skin and other body surfaces can develop deep bl...